Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$239,938
+$6,078 QoQ
Shares Held
1,531
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,237
of 1,603 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Portfolio Design Labs, LLC holds $28,086,107 across 10 Drug Manufacturers - General names. NVS ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,672 | $11,600,887 | |
| 2 | JNJ |
Johnson & Johnson
|
26,190 | $6,651,474 | |
| 3 | ABBV |
AbbVie Inc.
|
11,344 | $2,854,604 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,354 | $2,101,489 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,178 | $1,285,888 | |
| 6 | PFE |
Pfizer Inc
|
50,289 | $1,210,959 | |
| 7 | AMGN |
Amgen Inc
|
3,317 | $1,201,152 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,294 | $708,380 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,938 | 1,531 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $233,860 | 1,531 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $211,078 | 1,531 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $302,767 | 2,502 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $349,935 | 3,139 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $276,555 | 2,842 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||